Announcement

Collapse
No announcement yet.

Gilead’s remdesivir will cost $3,120 for patients with private insurance

Collapse
  • Filter
  • Time
  • Show
Clear All
new posts

    #21
    Originally posted by 4truth View Post
    Well, on the other hand.



    That's the trouble with these studies. Not very often do you get a clear undeniable result.
    I think the standards used here to claim a win are suspect...

    At Day 11, a higher proportion of patients in the 5-day treatment group achieved improvement in clinical status versus the standard of care group, achieving statistical significance for a ≥ 1-point improvement in ordinal scale (p=0.026). In addition, non-statistically significant increases in clinical worsening or death were observed in the standard of care only group compared with the remdesivir groups.

    I'm not convinced by their study that this is a break-through vs a money grab.
    Last edited by jaded; 06-30-2020, 05:33 PM.

    Comment


      #22
      You know that number doesn't even hit me as insane. Healthcare is dumb expensive

      Comment

      Working...
      X
      TOP